Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells

Cytokine

Volumn 12, Issue 8, 2000, Pages 1163-1170

  Ritter, Thomas ^a   Brandt, Christine ^a   Prösch, Susanna ^a   Vergopoulos, Athanasios ^a   Vogt, Katrin ^a   Kolls, Jay ^b   Volk, Hans Dieter ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokines; Gene therapy; hCMV IE promoter; Transgene expression

Indexed keywords

BETA GALACTOSIDASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADENOVIRUS; CONTROLLED STUDY; ENDOTHELIUM CELL; ESCHERICHIA COLI; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSCRIPTION REGULATION; TRANSGENE; VIRUS GENE;

ADENOVIRIDAE; ALPHAVIRUS; DNA VIRUSES; ESCHERICHIA COLI; HUMAN HERPESVIRUS 5;

EID: 0033868530     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.2000.0689     Document Type: Article

References (26)

1. Friedmann T. Human gene therapy - an immature genie, but certainly out of the bottle. Nat Med. 2:1996;144-147.
2. Wilson JM. Adenovirus as gene-delivery vehicles. N Engl J Med. 334:1996;1185-1187.
3. Yang Y, Jooss KU, Su Q, Ertl HC, Wilson JM. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3:1996;137-144.
4. Yang Y, Li Q, Ertl HC, Wilson JM. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J Virol. 69:1995;2004-2015.
5. Gribaudo G, Ravaglia S, Gaboli M, Gariglio M, Cavallo R, Landolfo S. Interferon-alpha inhibits the murine cytomegalovirus immediate-early gene expression by down-regulating NF-kappa B activity. Virology. 211:1995;251-260.
6. Harms JS, Splitter GA. Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC I promoter. Hum Gene Ther. 6:1995;1291-1297.
7. Tzen CY, Scott RE. Induction of SV40 early transcription by type I interferon. Exp Cell Res. 205:1993;246-250.
8. Stein J, Volk HD, Liebenthal C, Kruger HD, Prosch S. Tumor necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol. 74:1993;2333-2338.
9. Qin L, Ding Y, Pahud DR, Chang E, Imperiale MJ, Bromberg JS. Promoter attenuation in gene therapy: interferon-gamma and tumor necrosis factor-alpha inhibit transgene expression. Hum Gene Ther. 8:1997;2019-2029.
10. Kolls J, Peppel K, Silva M, Beutler B. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer. Proc Natl Acad Sci USA. 91:1994;215-219.
11. Crystal RG. The gene as a drug. Nat Med. 1:1995;15-17.
12. Fietze E, Prosch S, Reinke P, Stein J, Docke WD, Staffa G, Loning S, Devaux S, Emmrich F, Baehr von R. Cytomegalovirus infection in transplant recipients. Transplantation. 58:1994;657-680.
13. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature. 370:1994;153-157.
14. Ihle JN. Cytokine receptor signaling. Nature. 377:1995;591-594.
15. Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE. An IL-4 receptor region containing an insulin receptor motif is important for IL-4 mediated IRS-1 phosphorylation and cell growth. Cell. 5:1994;811-820.
16. Beg AA, Finco TS, Nantermet PV, Baldwin AS Jr. Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of I kappa B alpha: a mechanism for NF-kappa B activation. Mol Cell Biol. 13:1993;3301-3310.
17. Schutze S, Machleidt T, Kronke M. Mechanisms of tumor necrosis factor action. Semin Oncol. 19:1992;16-24.
18. Prösch S, Staak K, Stein J, Liebenthal C, Stamminger T, Volk HD, Krüger DH. Stimulation of the human cytomegalovirus IE enhancer/promoter in hL-60 cells by TNFa is mediated via induction of NF-kB. Virology. 208:1995;197-206.
19. Griffin GE, Leung K, Folks TM, Kunkel S, Nabel GJ. Induction of NF-κB during monocyte differentiation is associated with activation of HIV-gene expression. Research in Virology. 142:1991;233-238.
20. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
21. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass CK. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc Natl Acad Sci USA. 94:1997;1074-1079.
22. 2and cytokines. Exp Lung Res. 24:1998;3-14.
23. Finbloom DS, Winestock KD. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1a and STAT3 complexes in human T cells and monocytes. J Immunol. 155:1995;1079-1090.
24. Schröder, G, Risch, K, Nizze, H, Kolls, J, Reinke, P, Brock, J, Lehmann, M, Volk, HD, Ritter, T, Prolonged adenovirus-mediated gene expression in heart transplants by non-depleting anti-CD4 mab therapy.
25. Graham FL, Prvec L. Manipulation of adenovirus vectors. Murray EJ. Methods in Molecular Biology. 1991;109 The Humana Press Inc. Clifton.
26. Siegling A, Lehmann M, Platzer C, Emmrich F, Volk HD. A novel multispecific competitor fragment for quantitative PCR analysis of cytokine gene expression in rats. J Immunol Methods. 177:1994;23-28.